GO:0140938 histone H3 methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140938 histone H3 methyltransferase activity describes the enzymatic transfer of a methyl group from S-adenosyl-L-methionine to a histone H3 substrate, producing S-adenosyl-L-homocysteine and methylated histone H3.
• The COMPASS family of H3K4 methylases exemplifies how multi-subunit complexes achieve substrate specificity and regulate development and disease.
• Histone H3 methyltransferase activity is dynamically regulated by accessory proteins such as Caf1, MRG15, and Ash1, which sense unmodified histone H3 or recruit enzymes to nucleosomes.
• H3K4me1, deposited by H3K4 methyltransferases, facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation.
• Dysregulated histone H3 methyltransferase activity contributes to vascular aging, heterochromatin maintenance, and adipose tissue development.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise interrogation of histone H3 methyltransferase function in health and disease.
Description
Histone H3 methyltransferase activity (GO:0140938) is a molecular function defined as the catalysis of the reaction: S-adenosyl-L-methionine + a histone H3 = S-adenosyl-L-homocysteine + a methylated histone H3. This activity typically methylates lysine or arginine residues on histone H3, generating epigenetic marks that influence chromatin structure and gene expression. The COMPASS family of histone H3K4 methylases, for example, serves as a paradigm for how multi-subunit complexes achieve substrate specificity and regulate developmental gene expression programs. Because histone H3 methylation is central to transcriptional control, researchers across epigenetics, cancer biology, and developmental biology require reliable tools to study these enzymes. Understanding the mechanisms, key genes, and regulatory layers of histone H3 methyltransferase activity is therefore essential for both basic discovery and therapeutic development.
histone H3 methyltransferase activity At A Glance
| GO ID | GO:0140938 |
|---|---|
| GO term | histone H3 methyltransferase activity |
| Ontology | molecular_function |
| Synonym | histone H3 methylase activity, histone H3 methylation |
| Definition | Catalysis of the reaction: S-adenosyl-L-methionine + a histone H3 = S-adenosyl-L-homocysteine + a methylated histone H3. Histone methylation generally occurs on either an arginine or a lysine residue. |
| Major function | Transfer of a methyl group to histone H3, creating epigenetic marks that regulate chromatin and transcription. |
| Cofactor | S-adenosyl-L-methionine (SAM) serves as the methyl donor. |
| Substrate | Histone H3, typically at lysine or arginine residues. |
| Representative enzymes | COMPASS family H3K4 methylases, Smyd2, Ash1, SUV39H1/H2, MLL3/MLL4. |
What Is GO:0140938?
GO:0140938 histone H3 methyltransferase activity is the enzymatic activity that transfers a methyl group from the cofactor S-adenosyl-L-methionine (SAM) to a histone H3 protein, releasing S-adenosyl-L-homocysteine (SAH) and leaving the histone H3 methylated. The modification generally occurs on either an arginine or a lysine residue within the histone H3 tail. This activity is a molecular function that underlies epigenetic regulation, as the resulting methyl marks can alter chromatin compaction and recruit reader proteins that interpret the mark.
Why Is histone H3 methyltransferase activity Important in Cell Biology?
Histone H3 methyltransferase activity is a cornerstone of epigenetic regulation because it deposits methyl marks that directly influence chromatin architecture and gene expression programs. Dysregulation of these enzymes has been linked to diverse pathologies, including vascular aging, heterochromatin instability, and impaired adipose tissue development. Moreover, the activity is tightly controlled by accessory proteins and crosstalk with other histone modifications, making it a rich area for mechanistic studies. Researchers studying development, cancer, and aging therefore rely on accurate models to dissect how histone H3 methyltransferases contribute to normal physiology and disease.
• Histone H3 methyltransferase activity establishes epigenetic marks such as H3K4me1 that facilitate promoter-enhancer interactions and gene activation.
• The COMPASS family of H3K4 methylases regulates developmental gene expression and is implicated in disease pathogenesis.
• Smyd2, a histone H3 methyltransferase, drives vascular aging through its enhancer-dependent activity.
• Caf1 senses unmodified histone H3 to regulate the methyltransferase activity of Ash1, linking substrate recognition to enzyme control.
• MRG15 activates ASH1L by recruiting it to nucleosomes, demonstrating the importance of accessory factors.
• DNA hypomethylation promotes UHRF1- and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states.
• H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development.
• Histone H3 methyltransferase activity programs nuclear peripheral genome positioning.
• Dysregulated histone H3 methylation is associated with cancer, aging, and developmental disorders.
• CRISPR-based models enable causal testing of histone H3 methyltransferase genes in disease contexts.
What Happens During histone H3 methyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme first finds and grabs onto the histone H3 protein.
Histone H3 methyltransferases must recognize their substrate within the context of chromatin. For example, Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3, ensuring that methylation occurs only on appropriate substrates. Similarly, MRG15 activates ASH1L by recruiting it to nucleosomes, highlighting the importance of targeting modules in substrate engagement. The COMPASS family of H3K4 methylases also relies on specific subunit interactions to bind histone H3 and achieve methylation.
Methyl group transfer from SAM
In simple terms: The enzyme takes a methyl group from a donor molecule and attaches it to histone H3.
The catalytic step involves the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to a lysine or arginine residue on histone H3, yielding S-adenosyl-L-homocysteine (SAH) and methylated histone H3. This reaction is the defining biochemical event of GO:0140938. The COMPASS family enzymes, such as those mediating H3K4 methylation, catalyze this transfer with high specificity. The resulting methyl marks can be mono-, di-, or tri-methylated, depending on the enzyme and context.
Formation of methylated histone H3 products
In simple terms: The modified histone now carries a chemical tag that can be read by other proteins.
Following methyl transfer, the modified histone H3 serves as a docking site for reader proteins that interpret the mark. For instance, H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation. In another context, DNA hypomethylation promotes UHRF1- and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states. These downstream events illustrate how the methyl mark deposited by histone H3 methyltransferase activity translates into functional outcomes.
Regulation by accessory proteins and crosstalk
In simple terms: Other proteins can turn the enzyme on or off and coordinate its activity with other modifications.
Histone H3 methyltransferase activity is not constitutive; it is modulated by accessory factors and crosstalk with other histone modifications. Caf1 senses unmodified histone H3 to regulate Ash1 activity, while MRG15 activates ASH1L by recruiting it to nucleosomes. Smyd2 drives vascular aging through its enhancer-dependent activity, demonstrating that enhancer context can influence methyltransferase function. Additionally, H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4, showing that histone variants and mutations can impact enzyme stability and activity.
Key Genes Involved in GO:0140938 histone H3 methyltransferase activity
The following genes encode enzymes, subunits, or regulators associated with histone H3 methyltransferase activity (GO:0140938).
| Gene | Major Role | Research Relevance |
|---|---|---|
| KMT2A (MLL1) | Catalytic subunit of COMPASS family H3K4 methyltransferase | Developmental gene regulation and leukemia |
| KMT2B (MLL2) | H3K4 methyltransferase in COMPASS-like complexes | Neurological disorders and development |
| KMT2C (MLL3) | Enhancer-associated H3K4 methyltransferase | Adipose tissue development and enhancer regulation |
| KMT2D (MLL4) | Enhancer-associated H3K4 methyltransferase | Enhancer regulation and disease |
| ASH1L | Histone H3K36 methyltransferase activated by MRG15 | Nucleosome recruitment and gene activation |
| ASH1 | Histone methyltransferase regulated by Caf1 | Substrate sensing and enzyme regulation |
| SMYD2 | Histone H3 methyltransferase driving vascular aging | Vascular aging and enhancer-dependent activity |
| SUV39H1 | H3K9 methyltransferase involved in heterochromatin | Heterochromatin maintenance and crosstalk |
| SUV39H2 | H3K9 methyltransferase involved in heterochromatin | Heterochromatin maintenance and crosstalk |
| UHRF1 | Reader protein linking DNA methylation to histone modifications | Crosstalk between DNA and histone methylation |
| MRG15 | Activator of ASH1L methyltransferase | Recruitment to nucleosomes |
| CAF1 | Regulator of Ash1 by sensing unmodified H3 | Substrate recognition and enzyme control |
| H3F3A (H3.3) | Histone H3 variant subject to methylation | Histone variant dynamics and enhancer function |
| H3F3B (H3.3) | Histone H3 variant subject to methylation | Histone variant dynamics and enhancer function |
| WDR5 | Core subunit of COMPASS family complexes | Complex assembly and substrate presentation |
| RBBP5 | Core subunit of COMPASS family complexes | Complex assembly and regulation |
| ASH2L | Core subunit of COMPASS family complexes | Complex assembly and regulation |
How Is histone H3 methyltransferase activity Regulated?
Histone H3 methyltransferase activity is regulated at multiple levels, including substrate sensing, accessory protein recruitment, and crosstalk with other chromatin modifications. Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3, ensuring that methylation is coupled to the substrate state. MRG15 activates ASH1L by recruiting it to nucleosomes, demonstrating that targeting factors are essential for activity. Smyd2 drives vascular aging through its enhancer-dependent activity, indicating that enhancer context can modulate methyltransferase function. Additionally, DNA hypomethylation promotes UHRF1- and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states, linking histone H3 methylation to DNA methylation pathways. H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4, showing that histone mutations can impact enzyme stability and activity.
histone H3 methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMYD2 | Vascular aging | Knockout or overexpression in vascular smooth muscle cells |
| SUV39H1 | Heterochromatin instability | Point mutation or knockout in cancer cell lines |
| SUV39H2 | Heterochromatin instability | Knockout in embryonic stem cells |
| KMT2C (MLL3) | Adipose tissue development defects | Knock-in of H3.3K4M mutation in adipocytes |
| KMT2D (MLL4) | Adipose tissue development defects | Knock-in of H3.3K4M mutation in adipocytes |
Histone H3 methyltransferase activity in vascular aging
Smyd2, a histone H3 methyltransferase, drives vascular aging through its enhancer-dependent activity. This finding links histone H3 methylation to age-related vascular dysfunction and suggests that targeting Smyd2 or its regulatory network could mitigate vascular aging phenotypes.
Histone H3 methyltransferase activity and heterochromatin stability
DNA hypomethylation promotes UHRF1- and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states. This crosstalk highlights how histone H3 methyltransferase activity contributes to genome stability, and its disruption may lead to heterochromatin instability associated with disease.
Histone H3 methyltransferase activity in development and adipose tissue
H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development. This demonstrates that proper histone H3 methyltransferase activity is required for normal developmental processes, and its perturbation can lead to tissue-specific defects.
Histone H3 methyltransferase activity in gene regulation and disease pathogenesis
The COMPASS family of histone H3K4 methylases regulates developmental gene expression and is implicated in disease pathogenesis. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation, underscoring the importance of these enzymes in both normal development and disease states.
From histone H3 methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SMYD2 reduce vascular aging phenotypes? | SMYD2 knockout in vascular smooth muscle cells |
| Does a point mutation in SUV39H1 disrupt heterochromatin maintenance? | SUV39H1 point mutation knock-in in cancer cell lines |
| Does H3.3K4M destabilize MLL3/MLL4 and impair adipogenesis? | H3.3K4M knock-in in adipose progenitor cells |
| Does overexpression of ASH1L enhance H3K36 methylation? | ASH1L overexpression in HEK293T cells |
| Does Caf1 regulate Ash1 activity in vivo? | Caf1 knockout or knockdown in Drosophila or mammalian cells |
| Does MRG15 recruitment activate ASH1L on nucleosomes? | Tagged knock-in of MRG15 in embryonic stem cells |
How to Study the histone H3 methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide localization of histone H3 methylation marks | Mapping enhancer and heterochromatin regions |
| Mass spectrometry | Quantification of methylated histone H3 residues | Detecting novel methylation sites and stoichiometry |
| In vitro methyltransferase assay | Enzymatic activity using SAM and histone H3 substrate | Testing substrate specificity and regulation |
| CRISPR knockout screen | Loss-of-function effects on methylation marks | Identifying essential methyltransferase genes |
| CRISPR activation screen | Gain-of-function effects on methylation | Discovering activators of histone H3 methylation |
| Western blot | Protein levels and specific methylation marks | Validating changes in enzyme expression or activity |
| Co-immunoprecipitation | Protein-protein interactions | Identifying complex components like MRG15-ASH1L |
| RNA-seq | Transcriptional changes upon perturbation | Linking methylation to gene expression programs |
Chromatin immunoprecipitation followed by sequencing (ChIP-seq)
ChIP-seq using antibodies against specific histone H3 methylation marks (e.g., H3K4me1, H3K9me3) allows genome-wide mapping of methyltransferase activity products. This method is essential for understanding how histone H3 methyltransferase activity shapes enhancer and heterochromatin landscapes.
Mass spectrometry-based proteomics
Mass spectrometry can detect and quantify methylation on histone H3 residues, providing direct evidence of methyltransferase activity. This approach is useful for identifying novel methylation sites and assessing the impact of mutations in enzymes or substrates.
In vitro methyltransferase assays
Recombinant enzymes or immunoprecipitated complexes can be incubated with histone H3 substrates and radiolabeled or fluorescent SAM to measure methyltransferase activity. Such assays are used to dissect substrate specificity and the effects of regulatory proteins like Caf1 and MRG15.
CRISPR-based genetic screens
Pooled CRISPR knockout or activation screens can identify genes that regulate histone H3 methyltransferase activity or that are required for specific methylation marks. These screens are powerful for discovering novel components of the methylation machinery and their disease relevance.
How CRISPR Can Be Used to Study GO:0140938 histone H3 methyltransferase activity
Knockout
CRISPR knockout of histone H3 methyltransferase genes (e.g., SMYD2, SUV39H1) enables loss-of-function studies to determine their role in cellular processes and disease models. Knockout cell lines can be used to assess changes in methylation marks and downstream phenotypes.
Point Mutation
Point mutations in catalytic residues or regulatory domains of histone H3 methyltransferases can be introduced using CRISPR to dissect enzyme mechanism and substrate specificity. For example, mutations in the SET domain of Ash1 can reveal how Caf1 senses unmodified histone H3.
Knock-in
Knock-in of tagged or mutant histone H3 variants (e.g., H3.3K4M) allows tracking of methylation dynamics and effects on enzyme stability. This approach is valuable for studying how histone mutations impact methyltransferase activity and chromatin function.
Overexpression
CRISPR activation or cDNA overexpression of histone H3 methyltransferases (e.g., ASH1L, SMYD2) can be used to study gain-of-function effects on methylation and gene expression. Overexpression models help identify downstream targets and potential therapeutic vulnerabilities.
How EDITGENE Supports histone H3 methyltransferase activity Research
Researchers studying histone H3 methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific methylation event, developmental process, or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for histone H3 methyltransferase activity research.
Frequently Asked Questions About histone H3 methyltransferase activity
What is GO:0140938 histone H3 methyltransferase activity?
GO:0140938 is a molecular function term describing the catalysis of methyl group transfer from S-adenosyl-L-methionine to histone H3, producing S-adenosyl-L-homocysteine and methylated histone H3.
What genes are involved in histone H3 methyltransferase activity?
Key genes include KMT2A, KMT2B, KMT2C, KMT2D, ASH1L, ASH1, SMYD2, SUV39H1, SUV39H2, and their regulators such as MRG15 and Caf1.
How is histone H3 methyltransferase activity regulated?
It is regulated by accessory proteins like Caf1 and MRG15, which sense unmodified histone H3 or recruit enzymes to nucleosomes, as well as by crosstalk with DNA methylation and other histone modifications.
What diseases are associated with histone H3 methyltransferase activity?
Dysregulation has been linked to vascular aging, heterochromatin instability, impaired adipose tissue development, and cancer.
What is the role of H3K4 methylation in gene expression?
H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation.
How can I study histone H3 methyltransferase activity in the lab?
Common methods include ChIP-seq, mass spectrometry, in vitro methyltransferase assays, and CRISPR-based genetic screens.
What is the COMPASS family?
The COMPASS family comprises multi-subunit histone H3K4 methyltransferase complexes that regulate development and disease.
How does Caf1 regulate Ash1?
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3.
What is the role of MRG15 in histone methylation?
MRG15 activates ASH1L by recruiting it to nucleosomes.
Can CRISPR be used to study histone H3 methyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of these enzymes in health and disease.
Conclusion
Histone H3 methyltransferase activity (GO:0140938) is a fundamental epigenetic function that deposits methyl marks on histone H3, influencing chromatin structure and gene expression. Its dysregulation is implicated in vascular aging, heterochromatin instability, and developmental defects, making it a critical area of biomedical research. Advances in CRISPR-based models and multi-omics methods now allow researchers to dissect the causal roles of specific enzymes and their regulators. EDITGENE offers comprehensive services to support these investigations, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Shilatifard A. 2012. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.. Annu Rev Biochem 81:65-95 PMID: 22663077
- 2. See K et al.. 2020. Histone methyltransferase activity programs nuclear peripheral genome positioning.. Dev Biol 466(1-2):90-98 PMID: 32712024
- 3. Yoon E et al.. 2023. Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3.. Epigenetics Chromatin 16(1):15 PMID: 37118845
- 4. Su Z et al.. 2022. Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.. Aging (Albany NY) 15(1):70-91 PMID: 36585926
- 5. Kubo N et al.. 2024. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation.. Mol Cell 84(9):1742-1752.e5 PMID: 38513661
- 6. Al-Harthi S et al.. 2023. MRG15 activates histone methyltransferase activity of ASH1L by recruiting it to the nucleosomes.. Structure 31(10):1200-1207.e5 PMID: 37527654
- 7. Liu Y et al.. 2025. DNA hypomethylation promotes UHRF1-and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states.. Mol Cell 85(2):394-412.e12 PMID: 39631394
- 8. Jang Y et al.. 2019. H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development.. Nucleic Acids Res 47(2):607-620 PMID: 30335158
